covishield

Bharat Biotech, a Hyderabad-based vaccine manufacturer, has got the approval to conduct Covaxin booster trials for population below 18. According to a source, Bharat Biotech has sought…

Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue immediately to avoid cancellation of…

Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave, according to a new study that covered around 6,000 people…

FDA granted IND clearance today for STI-9167 (Intravenous COVISHIELD™) for a Phase 1 safety and pharmacokinetic study in healthy volunteers.Initial trials are expected to be followed by a…

The Serum Institute of India has urged the Centre to use the available 10 crore doses of Covishield offered free of cost by GAVI under COVAX facility in view of rising COVID-19 cases in the…

Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard…

"For practical purposes also we have appealed to the government to bring down the gap for booster dose from nine months to six months," says Adar Poonawalla, CEO, Serum Institute of India.…

With two key vaccine makers slashing the prices of their Covid-19 shots on Saturday, private hospitals are in a fix as the current stock was purchased at previously approved government…

PTI New Delhi, April 10 A day after slashing the price of the precaution dose of Covishield to Rs…

A day before the Covid-19 booster shoot drive is rolled out, both major vaccine manufacturers went on to announce a massive price cut on their vaccines. The Covid-19 vaccines Covishied…